Get all your news in one place.
100's of premium titles.
One app.
Start reading
The Conversation
The Conversation
Padmashree Gehl Sampath, Global Access in Action Program, Berkman Klein Center, Harvard University

African vaccines: local manufacturers are struggling to access the market - what must change

Afrigen, a biotechnology company based in Cape Town, South Africa was recently visited by WHO DG Dr Tedros. Kristin Palitza/picture alliance via Getty Images

Two recent developments in South Africa have underscored the opportunities – and challenges – facing vaccine production on the continent.

One was the visit by the World Health Organisation Director General Dr Tedros Adhanom Ghebreyesus to take stock of Africa’s mRNA vaccine hub. The hub was launched in mid-2021 in a bid to make the latest vaccine technology more readily available to developing countries.

Sign up to read this article
Read news from 100's of titles, curated specifically for you.
Already a member? Sign in here
Related Stories
Top stories on inkl right now
One subscription that gives you access to news from hundreds of sites
Already a member? Sign in here
Our Picks
Fourteen days free
Download the app
One app. One membership.
100+ trusted global sources.